在治疗刺激性肠综合征时常见的误解和争议
Christopher J Black1,2, Carolina Olano3, Eamonn M M Quigley4
1Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
Nature reviews. Gastroenterology & hepatology
|April 25, 2025
概括
这一观点解决了易发性肠综合征 (IBS) 管理中的常见误解和争议. 它旨在澄清已解决的问题,并讨论正在进行的辩论,以改善临床实践和患者护理.
科学领域:
- 胃肠病学 胃肠病学
- 神经胃肠病学 神经胃肠病学
- 肠-大脑轴研究研究
背景情况:
- 刺激性肠综合征 (IBS) 病理生理学涉及异常的肠-大脑轴通信.
- 尽管取得了进展,但IBS的临床治疗仍面临着持续的误解和争议.
- 现有的治疗方法包括药理学和非药理学方法.
研究的目的:
- 突出IBS临床管理中的常见误解和争议.
- 解决科学文献已经解决了争论但临床实践落后的领域.
- 讨论正在进行的争议领域,并提出解决方案.
主要方法:
- 视角的作品综合了当前的理解和临床挑战.
- 审查科学文献,以确定IBS管理中已解决和尚未解决的问题.
- 对临床实践缺口和医疗保健提供者的教育需求的分析.
主要成果:
- 关于IBS管理的几个先前讨论过的方面,现在已经得到了科学解决.
- 在临床医生中仍然存在误解,阻碍了最佳的患者护理.
- 目前存在争议的领域需要进一步的研究和临床指导方针的完善.
结论:
- 加强临床医生教育对于实施基于证据的IBS管理至关重要.
- 解决持久的误解可以改善患者的治疗结果.
- 需要进一步的研究和基于实践的创新来解决IBS护理中的剩余争议.
相关概念视频
Irritable Bowel Syndrome III: Medical and Nursing Management
117
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
117
Irritable Bowel Syndrome I: Introduction
203
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
203
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
96
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
96
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
236
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
236
Drugs for Treatment of Diarrhea-Predominant IBS
117
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
117
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80


